172 related articles for article (PubMed ID: 20623514)
1. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins.
Benyamini H; Friedler A
J Mol Recognit; 2011; 24(2):266-74. PubMed ID: 20623514
[TBL] [Abstract][Full Text] [Related]
2. A model for the interaction between NF-kappa-B and ASPP2 suggests an I-kappa-B-like binding mechanism.
Benyamini H; Leonov H; Rotem S; Katz C; Arkin IT; Friedler A
Proteins; 2009 Nov; 77(3):602-11. PubMed ID: 19507243
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism.
Rotem-Bamberger S; Katz C; Friedler A
PLoS One; 2013; 8(3):e58470. PubMed ID: 23472201
[TBL] [Abstract][Full Text] [Related]
4. Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2.
Rotem S; Katz C; Friedler A
Biochem Soc Trans; 2007 Nov; 35(Pt 5):966-9. PubMed ID: 17956256
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins.
Skene-Arnold TD; Luu HA; Uhrig RG; De Wever V; Nimick M; Maynes J; Fong A; James MN; Trinkle-Mulcahy L; Moorhead GB; Holmes CF
Biochem J; 2013 Feb; 449(3):649-59. PubMed ID: 23088536
[TBL] [Abstract][Full Text] [Related]
6. The structure and interactions of the proline-rich domain of ASPP2.
Rotem S; Katz C; Benyamini H; Lebendiker M; Veprintsev D; Rüdiger S; Danieli T; Friedler A
J Biol Chem; 2008 Jul; 283(27):18990-9. PubMed ID: 18448430
[TBL] [Abstract][Full Text] [Related]
7. Highly homologous proteins exert opposite biological activities by using different interaction interfaces.
Amir AI; van Rosmalen M; Mayer G; Lebendiker M; Danieli T; Friedler A
Sci Rep; 2015 Jul; 5():11629. PubMed ID: 26130271
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2.
Katz C; Benyamini H; Rotem S; Lebendiker M; Danieli T; Iosub A; Refaely H; Dines M; Bronner V; Bravman T; Shalev DE; Rüdiger S; Friedler A
Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12277-82. PubMed ID: 18719108
[TBL] [Abstract][Full Text] [Related]
9. Factor inhibiting HIF-1 (FIH-1) modulates protein interactions of apoptosis-stimulating p53 binding protein 2 (ASPP2).
Janke K; Brockmeier U; Kuhlmann K; Eisenacher M; Nolde J; Meyer HE; Mairbäurl H; Metzen E
J Cell Sci; 2013 Jun; 126(Pt 12):2629-40. PubMed ID: 23606740
[TBL] [Abstract][Full Text] [Related]
10. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.
Ahn J; Byeon IL; Byeon CH; Gronenborn AM
J Biol Chem; 2009 May; 284(20):13812-13822. PubMed ID: 19246451
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression pattern of the ASPP family of proteins in human non-small cell lung cancer and regulatory functions on apoptosis through p53 by iASPP.
Li S; Shi G; Yuan H; Zhou T; Zhang Q; Zhu H; Wang X
Oncol Rep; 2012 Jul; 28(1):133-40. PubMed ID: 22552744
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma.
Zhao J; Wu G; Bu F; Lu B; Liang A; Cao L; Tong X; Lu X; Wu M; Guo Y
Hepatology; 2010 Jan; 51(1):142-53. PubMed ID: 20034025
[TBL] [Abstract][Full Text] [Related]
13. ASPP and iASPP: Implication in cancer development and progression.
Li Y; Ahmad A; Sarkar FH
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):2-8. PubMed ID: 26518890
[TBL] [Abstract][Full Text] [Related]
14. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax.
Patel S; George R; Autore F; Fraternali F; Ladbury JE; Nikolova PV
Nucleic Acids Res; 2008 Sep; 36(16):5139-51. PubMed ID: 18676979
[TBL] [Abstract][Full Text] [Related]
15. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human.
Bergamaschi D; Samuels Y; O'Neil NJ; Trigiante G; Crook T; Hsieh JK; O'Connor DJ; Zhong S; Campargue I; Tomlinson ML; Kuwabara PE; Lu X
Nat Genet; 2003 Feb; 33(2):162-7. PubMed ID: 12524540
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73.
Robinson RA; Lu X; Jones EY; Siebold C
Structure; 2008 Feb; 16(2):259-68. PubMed ID: 18275817
[TBL] [Abstract][Full Text] [Related]
17. Flexible Tethering of ASPP Proteins Facilitates PP-1c Catalysis.
Zhou Y; Millott R; Kim HJ; Peng S; Edwards RA; Skene-Arnold T; Hammel M; Lees-Miller SP; Tainer JA; Holmes CFB; Glover JNM
Structure; 2019 Oct; 27(10):1485-1496.e4. PubMed ID: 31402222
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel isoform of iASPP and its interaction with p53.
Zhang X; Diao S; Rao Q; Xing H; Liu H; Liao X; Wang M; Wang J
J Mol Biol; 2007 May; 368(4):1162-71. PubMed ID: 17391696
[TBL] [Abstract][Full Text] [Related]
19. Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53.
Liu ZJ; Lu X; Zhang Y; Zhong S; Gu SZ; Zhang XB; Yang X; Xin HM
FEBS Lett; 2005 Mar; 579(7):1587-90. PubMed ID: 15757645
[TBL] [Abstract][Full Text] [Related]
20. p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation.
Sun WT; Hsieh PC; Chiang ML; Wang MC; Wang FF
Biochem Biophys Res Commun; 2008 Nov; 376(2):395-8. PubMed ID: 18793611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
